Research and analysis
Hydroxychloroquine or chloroquine, in combination with macrolide antibiotics: review of epidemiological data for cardiovascular safety
Public Assessment Report on our review of epidemiological data for cardiovascular safety.
Documents
PDF, 272 KB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 54.3 KB, 1 page
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 53.9 KB, 1 page
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 54.1 KB, 1 page
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 53.2 KB, 1 page
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
The aim of our Safety Public Assessment Reports is to present evidence-based assessments of safety issues for a particular drug or drug class.
The report provides a summary of the review of available safety data on the cardiovascular safety of hydroxychloroquine and chloroquine when these medicines are used on their own or in combination with the macrolide antibiotics azithromycin, clarithromycin or erythromycin.
Updates to this page
Published 15 February 2022